A clinical trial conducted by Prof. Alexandra Durr's team (Sorbonne University.AP-HP) at the Paris Brain Institute and the Pitié-Salpêtrière Hospital AP-HP shows that despite the hopes raised in ...
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive neurodegenerative disorder caused by a CAG ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Riluzole did not improve clinical or radiological ...
SALT LAKE CITY - Scientists report a significant step toward combatting two degenerative brain diseases that chip away at an individual's ability to move, and think. A targeted therapy developed by ...
Adult-onset SCA2 is characterized by progressive ataxia, extremely slow saccades, dysarthria, supranuclear ophthalmoplegia, cognitive impairment, peripheral neuropathy, as well as action or postural ...
An expanded repeat region in the ataxin-2 gene causes spinocerebellar ataxia or boosts risk for amyotrophic lateral sclerosis, leading scientists to believe it was only a matter of time before they ...
A defective response to DNA damage is observed in several human autosomal recessive ataxias with oculomotor apraxia, including ataxiatelangiectasia. We report that senataxin, defective in ataxia ...
Human bones may benefit from lots of dietary calcium, but brain cells are another matter. Too much calcium in certain neurons—or too little—can lead to neurological disorders such as ataxia, epilepsy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback